Effect of Fasting on the Non-invasive Measurement of the Body's Water Compartments
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04665349 |
|
Recruitment Status :
Completed
First Posted : December 11, 2020
Last Update Posted : December 11, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Preoperative fasting is defined as refraining from food for at least 6 hours and clear fluids for at least 2 hours prior to anaesthesia. On the one hand, it is a procedure that reduces the risk of aspiration of food content and the occurrence of Mendelson's syndrome, and on the other hand, it was considered to be the cause of disturbances in water management in patients undergoing general anaesthesia. However, reports from recent years have found that moderate preoperative fasting does not influence the risk of hypovolemia in anesthetized patients. It is also known that in fasting people the total body water is reduced. Thus, it can be assumed that there are mechanisms causing the movement of extravascular water into the lumen of blood vessels. For several years, the Body Composition Monitor (BCM) device for non-invasive measurement of the volume of individual water compartments of the human body has been available on the market. It allows to determine the volume of total body water, intracellular body water and extracellular body water. It is mainly used during dialysis, but it can also be used in other circumstances that require the determination of the body's hydration status. The principle of this method is based on non-invasive bioimpedance measurement with the use of 4 electrodes placed on two extremities.
The aim of the study is to determine whether there is a fluid shift between the intracellular and extracellular compartments in people undergoing preoperative fasting. Examination of this issue would allow for the development of hypothesis regarding the optimal perioperative fluid therapy. If there was a shift of fluid from the intracellular space, it seems more rational to supplement fluid deficiencies resulting from starvation with a 5% glucose solution. If, on the other hand, no fluid shift from the intracellular space was detected, which would suggest shifts within the extracellular space, it would be advisable to hydrate the patient with crystalloid solutions.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Dehydration Perioperative Complication | Dietary Supplement: Nutricia Pre-op, 400 milliliters, per os | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 81 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Effect of Fasting on the Non-invasive Measurement of the Body's Water Compartments |
| Actual Study Start Date : | November 20, 2019 |
| Actual Primary Completion Date : | October 12, 2020 |
| Actual Study Completion Date : | October 13, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Pre-op
Nutricia Pre-op, 400 milliliters, per os
|
Dietary Supplement: Nutricia Pre-op, 400 milliliters, per os
After 10 hours of fasting participants will receive per os 400 milliliters of Nutricia Pre-op |
|
No Intervention: Control
No intervention
|
- Amount of total body water [ Time Frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration ]Measurements will be done with Fresenius Body Composition Monitor
- Extracellular to intracellular water ratio [ Time Frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration ]Measurements will be done with Fresenius Body Composition Monitor
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- American Society of Anesthesiology (ASA) general condition assessment 1 or 2
Exclusion Criteria:
- Chronic kidney disease
- Circulatory failure
- Phenylketonuria
- History of hypoglycaemic episodes or any carbohydrate metabolism disorders.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04665349
| Poland | |
| Medical University of Gdansk - Departament of Anesthesiology and Intensive Care | |
| Gdańsk, Pomorskie, Poland, 80-210 | |
| Principal Investigator: | Radosław Owczuk, Professor | Medical University of Gdansk |
| Responsible Party: | Radosław Owczuk, Clinical Professor, Head of Department of Anaesthesiology and Intensive Care, Medical University of Gdansk |
| ClinicalTrials.gov Identifier: | NCT04665349 |
| Other Study ID Numbers: |
NKBBN/126/2014 |
| First Posted: | December 11, 2020 Key Record Dates |
| Last Update Posted: | December 11, 2020 |
| Last Verified: | December 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Dehydration Water-Electrolyte Imbalance Metabolic Diseases Pathologic Processes |

